These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 35769085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
    Ezeh U, Ezeh C, Pisarska MD, Azziz R.
    Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
    [Abstract] [Full Text] [Related]

  • 3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome.
    Hussein K, Karami M.
    Saudi Pharm J; 2023 Jun 07; 31(6):1104-1108. PubMed ID: 37293383
    [Abstract] [Full Text] [Related]

  • 8. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
    El-Eshmawy MM, Ibrahim A, Bahriz R, Shams-Eldin N, Mahsoub N.
    BMC Endocr Disord; 2022 Dec 13; 22(1):315. PubMed ID: 36514085
    [Abstract] [Full Text] [Related]

  • 9. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U, Pall M, Mathur R, Azziz R.
    Hum Reprod; 2014 Jul 13; 29(7):1508-17. PubMed ID: 24813197
    [Abstract] [Full Text] [Related]

  • 10. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J.
    Arch Gynecol Obstet; 2013 Mar 13; 287(3):525-31. PubMed ID: 23108387
    [Abstract] [Full Text] [Related]

  • 11. Serum HLA-G levels in women with polycystic ovary syndrome.
    Oztekin O, Fenkci SM, Fenkci V, Enli Y, Cabus U.
    Gynecol Endocrinol; 2015 Mar 13; 31(3):243-6. PubMed ID: 25403326
    [Abstract] [Full Text] [Related]

  • 12. Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome.
    Mansour A, Hashemi Taheri AP, Moradi B, Mohajeri-Tehrani MR, Qorbani M, Ghorbani Pashakolaee S, Sanginabadi M, Sajjadi-Jazi SM.
    BMC Endocr Disord; 2022 Dec 01; 22(1):298. PubMed ID: 36456925
    [Abstract] [Full Text] [Related]

  • 13. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun 01; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 14. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
    Enli Y, Fenkci SM, Fenkci V, Oztekin O.
    Gynecol Endocrinol; 2013 Dec 01; 29(12):1036-9. PubMed ID: 23961784
    [Abstract] [Full Text] [Related]

  • 15. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA, Shin SY, Yoon BK, Choi D.
    Gynecol Endocrinol; 2007 Dec 01; 23(8):461-7. PubMed ID: 17852414
    [Abstract] [Full Text] [Related]

  • 16. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov 01; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 17. Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome.
    Ezeh U, Chen YI, Pall M, Buyalos RP, Chan JL, Pisarska MD, Azziz R.
    Fertil Steril; 2024 Jun 01; 121(6):1040-1052. PubMed ID: 38307453
    [Abstract] [Full Text] [Related]

  • 18. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S, Akhtar N, Ahmad J.
    Diabetes Metab Syndr; 2012 Jun 01; 6(4):207-11. PubMed ID: 23199540
    [Abstract] [Full Text] [Related]

  • 19. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
    Zhang H, Wang W, Zhao J, Jiao P, Zeng L, Zhang H, Zhao Y, Shi L, Hu H, Luo L, Fukuzawa I, Li D, Li R, Qiao J.
    Front Endocrinol (Lausanne); 2022 Jun 01; 13():1085656. PubMed ID: 36699018
    [Abstract] [Full Text] [Related]

  • 20. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY, Ma Y, Lu XH, Liang XH, Suo YJ, Huang ZX, Lu DC, Qin YF, Luo ZJ.
    Ann Endocrinol (Paris); 2015 Oct 01; 76(5):620-7. PubMed ID: 26514948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.